| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Article |
1 Service de Gynécologie-Obstétrique, Hôpital Tenon, AP-HP, 4 Rue de la Chine, CancerEst, UFR Saint-Antoine, 75020 Paris VI, France
2 UFR SMBH Léonard De Vinci, Université Paris XIII, 93017 Bobigny Cedex, Paris, France
Correspondence: Address correspondence and reprint requests to: Emile Daraï, MD, PhD; E-mail: emile.darai{at}tnn.ap-hop-paris.fr.
Background: Fertility-sparing surgery for borderline ovarian tumors (BOT) is feasible and effective and does not seem to have a negative effect on survival. Specific data on the effect of cystectomy, and notably on recurrence, are lacking.
Methods: This was a French retrospective multicenter study of 313 women with stage I BOT treated from 1990 to 2000 in 13 specialized gynecological units and 1 cancer center. Diagnosis and staging were based on International Federation of Gynecology and Obstetrics (1989) criteria. Surgery consisted of cystectomy, unilateral salpingo-oophorectomy (USO), or bilateral salpingo-oophorectomy (BSO).
Results: After cystectomy, persistent BOT and benign ovarian cysts on the operated ovary were observed in 15% and 65% of patients, respectively. Mean follow-up did not differ among patients receiving the three types of surgery. The recurrences after cystectomy, USO, and BSO treatment were 30.3%, 11%, and 1.7%, respectively (P < .0001). Recurrences were more frequent after cystectomy than after USO (P = .0001) and BSO (P = .0001) and when intraoperative cyst rupture occurred (P = .04).
Conclusions: These results suggest that cystectomy for BOT is associated with a high risk of intraoperative cyst rupture and of recurrence compared with USO or BSO.
Key Words: Borderline ovarian tumors Recurrence Cystectomy Persistent tumor Salpingo-oophorectomy
This article has been cited by other articles:
![]() |
A. N. Fader and P. G. Rose Role of Surgery in Ovarian Carcinoma J. Clin. Oncol., July 10, 2007; 25(20): 2873 - 2883. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |